Allergy Research Group
Hypoallergenic supplements backed by research
Applications Engineer
About the job
- A Bachelor's Degree in a technical discipline.
- At least 3 years of experience in a customer-centric engineering role such as Applications, Sales, or Product Engineering, or 5 years of experience directly related to the required duties and responsibilities in lieu of a formal degree.
- Technical industry knowledge in appliances, consumer goods, automotive, commercial vehicles, power distribution, capital equipment, medical devices, and/or technology.
- Ability to read and understand drawings with the associated manufacturing requirements.
- Skill in using business software and technology.
- Assist in qualifying specific requests for quotation and participate as needed in preparing and presenting proposals for qualified new business prospects in coordination with the Business Development and Account Manager teams.
- Develop business opportunities through site visits, emails, and phone correspondence.
- Develop solutions to prospect requirements that meet technical needs and provide increased value through Value Analysis and Design for Manufacture support.
- Provide guidance and support in the cost-estimating process in coordination with Cost Analysts and work with Sales to prepare competitive proposals for new business.
- Provide technical support for managing new programs, working with New Product Introduction and plant Project Leads to speed the transition through first article and Production Part Approval Process to production start-up.
- Provide ongoing technical assistance to the Account Management team regarding component selection, engineering change evaluations, and Value Analysis initiatives.
- Expertise in design and manufacturing processes.
About the company
Allergy Research Group makes hypoallergenic dietary supplements using pure raw materials. They source ingredients and develop formulations designed to minimize allergen exposure, backed by scientific research. The products deliver nutrients or bioactive compounds in hypoallergenic forms and follow strict quality controls to avoid common allergens and contaminants. The company differentiates itself through its long history (since 1979), emphasis on hypoallergenic ingredient profiles, and evidence-based formulation rather than relying on trend-driven products. Its goal is to provide safe, effective nutritional supplements for people with allergies or sensitivities that support health without triggering allergic reactions.
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
South Salt Lake, Utah
Founded
1979
Get referred to Allergy Research Group
See people who can refer or advise you
Simplify's Take
What believers are saying
- February 2026 peer-reviewed thyroid paper gives sales teams fresh clinical credibility.
- Metabolic Maintenance integration adds stress and mood products, expanding wallet share in 2025.
- New products page updated May 5, 2026 signals active pipeline and ongoing catalog refresh.
What critics are saying
- SupplementChecker lists two recalls and one adverse event, pressuring trust with practitioners.
- 2004 FDA warning letter shows recurring claims-compliance risk if marketing overstates benefits.
- WM Partners ownership since 2023 creates exit pressure; underperforming integration can force a sale.
What makes Allergy Research Group unique
- 45-plus years in hypoallergenic, practitioner-focused supplements differentiates ARG from mass brands.
- February 4, 2026 endocrine science publication strengthens ARG’s evidence-based positioning.
- January 2025 Metabolic Maintenance acquisition broadened ARG beyond allergy into mood and metabolic categories.
Help us improve and share your feedback! Did you find this helpful?
Growth & Insights and Company News
6 month growth
↑ 7%1 year growth
↑ 7%2 year growth
↑ 7%WM Partners, a certified diverse-owned private equity firm focused on investing in middle market companies and driving value creation in the health and wellness sector, today announced that HPH III Investments, LP, together with its parallel and feeder funds (“HPH III”), through its wholly owned entity, has acquired Allergy Research Group, a subsidiary of KI NutriCare (“KIN”), from Kikkoman Corporation.
WM Partners has acquired Allergy Research Group, a hypoallergenic supplement retailer founded in 1979, from Kikkoman subsidiary KI Nutricare.
WM Partners announces acquisition of Allergy Research Group.